ArticleInternational journal of medical sciences2022
Real-world clinical outcomes of treatment with casirivimab-imdevimab among patients with mild-to-moderate coronavirus disease 2019 during the Delta variant pandemic.
Open access · goldAbstract read
In one paragraph
Article in International journal of medical sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 30% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.
- Efficacy and safety of sotrovimab in patients with COVID-19: A rapid review and meta-analysis.Reviews in medical virology · 2022Pooled it
- Casirivimab-imdevimab treatment is associated with reduced rates of mortality and hospitalization in patients with COVID-19: A systematic review with meta-analysis.The Journal of infection · 2023Article
- Long-Term Vaccination and Treatment Strategies for COVID-19 Disease and Future Coronavirus Pandemics.Advances in experimental medicine and biology · 2023Review
- Clinical effect of early administration of tocilizumab following the initiation of corticosteroid therapy for patients with COVID-19.Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
49 authors at 13 institutions in 1 country.
Yasuhito SuzukiDepartment of Pulmonary Medicine, Fukushima Medical University, Fukushima, Japan.
Yoko ShibataDepartment of Pulmonary Medicine, Fukushima Medical University, Fukushima, Japan.
Hiroyuki MinemuraDepartment of Pulmonary Medicine, Fukushima Medical University, Fukushima, Japan.
Takefumi NikaidoDepartment of Pulmonary Medicine, Fukushima Medical University, Fukushima, Japan.
Yoshinori TaninoDepartment of Pulmonary Medicine, Fukushima Medical University, Fukushima, Japan.
Atsuro FukuharaDepartment of Pulmonary Medicine, Fukushima Medical University, Fukushima, Japan.
Ryuzo KannoDepartment of Thoracic Surgery, Fukushima Red Cross Hospital, Fukushima, Japan.
Hiroyuki SaitoDepartment of Internal Medicine, Fujita General Hospital, Fukushima, Japan.
Shuzo SuzukiDepartment of Internal Medicine, Fujita General Hospital, Fukushima, Japan.
Taeko IshiiDepartment of Pulmonary Medicine, Saiseikai Fukushima General Hospital, Fukushima, Japan.
Yayoi InokoshiDepartment of Pulmonary Medicine, Saiseikai Fukushima General Hospital, Fukushima, Japan.
Eiichiro SandoDepartment of General Internal Medicine and Clinical Infectious Diseases, Fukushima Medical University, Fukushima, Japan.
Hirofumi SakumaDepartment of Internal Medicine, Saiseikai Kawamata Hospital, Fukushima, Japan.
Tatsuho KobayashiDepartment of Emergency and Critical Care Medicine, Aizu Chuo Hospital, Fukushima, Japan.
Hiroaki KumeDepartment of Infectious Disease and Pulmonary Medicine, Aizu Medical Center, Fukushima Medical University, Fukushima, Japan.
Masahiro KamimotoDepartment of Internal Medicine, Takeda General Hospital, Fukushima, Japan.
Hideko AokiDepartment of Pediatric Medicine, Bange Kousei General Hospital, Fukushima, Japan.
Akira TakamaDepartment of Surgery, Yurin Hospital, Fukushima, Japan.
Takamichi KamiyamaDepartment of Pediatric Surgery, Iwaki City Medical Center, Fukushima, Japan.
Masaru NakayamaDepartment of Internal Medicine, Kashima Hospital, Fukushima, Japan.
Kiyoshi SaitoDepartment of Neurosurgery, Fukushima Rosai Hospital, Fukushima, Japan.
Koichi TanigawaDepartment of Emergency and Critical Care Medicine, Futaba Medical Center, Fukushima, Japan.
Masahiko SatoDepartment of Internal Medicine, Soma General Hospital, Fukushima, Japan.
Toshiyuki KanbeDepartment of Pulmonary Medicine, Minami-Soma Municipal General Hospital, Fukushima, Japan.
Norio KanzakiDepartment of Surgery, Onahama Chuo Clinic, Fukushima, Japan.
Teruhisa AzumaDepartment of General Medicine, Shirakawa Satellite for Teaching and Research, Fukushima Medical University, Fukushima, Japan.
Keiji SakamotoDepartment of Cardiology and Vascular Medicine, Hoshi General Hospital, Fukushima, Japan.
Yuichi NakamuraDepartment of Cardiology and Vascular Medicine, Hoshi General Hospital, Fukushima, Japan.
Hiroshi OhtaniDepartment of Internal Medicine, Iwase General Hospital, Sukagawa, Japan.
Mitsuru WaragaiDepartment of Surgery, Southern TOHOKU General Hospital, Fukushima, Japan.
Shinsaku MaedaDepartment of Pulmonary Medicine, Jusendo General Hospital, Fukushima, Japan.
Tokiya IshidaDepartment of Emergency and Critical Care Medicine, Ohta Nishinouchi Hospital, Fukushima, Japan.
Keishi SuginoDepartment of Respiratory Medicine, Tsuboi Hospital, Fukushima, Japan.
Yasuhiko TsukadaDepartment of Emergency and Critical Care Medicine, Fukushima Medical University, Fukushima, Japan.
Ryuki YamadaDepartment of Pulmonary Medicine, Fukushima Medical University, Fukushima, Japan.
Riko SatoDepartment of Pulmonary Medicine, Fukushima Medical University, Fukushima, Japan.
Takumi OnumaDepartment of Pulmonary Medicine, Fukushima Medical University, Fukushima, Japan.
Hikaru TomitaDepartment of Pulmonary Medicine, Fukushima Medical University, Fukushima, Japan.
Mikako SaitoDepartment of Pulmonary Medicine, Fukushima Medical University, Fukushima, Japan.
Natsumi WatanabeDepartment of Pulmonary Medicine, Fukushima Medical University, Fukushima, Japan.
Mami RikimaruDepartment of Pulmonary Medicine, Fukushima Medical University, Fukushima, Japan.
Takaya KawamataDepartment of Pulmonary Medicine, Fukushima Medical University, Fukushima, Japan.
Takashi UmedaDepartment of Pulmonary Medicine, Fukushima Medical University, Fukushima, Japan.
Julia MorimotoDepartment of Pulmonary Medicine, Fukushima Medical University, Fukushima, Japan.
Ryuichi TogawaDepartment of Pulmonary Medicine, Fukushima Medical University, Fukushima, Japan.
Yuki SatoDepartment of Pulmonary Medicine, Fukushima Medical University, Fukushima, Japan.
Junpei SaitoDepartment of Pulmonary Medicine, Fukushima Medical University, Fukushima, Japan.
Kenya KanazawaDepartment of Pulmonary Medicine, Fukushima Medical University, Fukushima, Japan.
Ken IsekiDepartment of Emergency and Critical Care Medicine, Fukushima Medical University, Fukushima, Japan.
Fukushima Medical University · JPChiba-Nishi General Hospital · JPFukushima Medical University Hospital · JPAsanogawa General Hospital · JPFutaba (Japan) · JPGunma Chuo Hospital · JPIjinkai Takeda General Hospital · JPOhta Nishinouchi Hospital · JPSendai Kousei Hospital · JPSoma Central Hospital · JPSouthern Tohoku General Hospital · JPTokushima Red Cross Hospital · JPToshima Hospital · JP
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
COVID-19 Drug TreatmentPandemicsAntibodies, Monoclonal, HumanizedHumansSARS-CoV-2Treatment OutcomeAntibodies, Monoclonal, Humanizedcasirivimabimdevimabcasirivimab-imdevimabCOVID-19Delta variantreal-world effectivenessSARS-CoV-2
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.